Biocon Annual Results

FINANCIALS

Select Period:

Particulars ( Rupees In Crores.)	Mar-2022	Mar-2021	Mar-2020	Mar-2019	Mar-2018
Gross Sales	8,184	7143.10	6300.50	5514.40	4129.70
Excise Duty	--	--	--	--	6.30
Net Sales	8,184	7143.10	6300.50	5514.40	4123.40
Other Operating Income	--	--	--	--	--
Other Income	212.70	267.10	228.90	339.90	227.50
Total Income	8396.70	7410.20	6529.40	5854.30	4350.90
Total Expenditure	6531.80	5569.70	4726.30	4120.70	3294.30
PBIDT	1864.90	1840.50	1803.10	1733.60	1056.60
Interest	67.60	57.70	64.90	70.90	61.50
PBDT	1797.30	1782.80	1738.20	1662.70	995.10
Depreciation	814.20	715.10	552.20	447.80	385.10
Minority Interest Before NP	--	--	--	--	--
Tax	211.50	221.50	315.10	212.30	156.90
Deferred Tax	--	--	--	--	--
Reported Profit After Tax	771.60	846.20	870.90	1002.60	453.10
Minority Interest After NP	123.20	105.70	122.70	97.30	80.70
Net Profit after Minority Interest	648.40	740.50	748.20	905.30	372.40
Extra-ordinary Items	(87.20)	9.99	49.99	160.59	--
Adjusted Profit After Extra-ordinary item	735.60	730.51	698.21	744.71	372.40
EPS (Unit Curr.)	5.44	6.24	6.32	15.30	6.31
Book Value (Unit Curr.)	--	--	--	--	--
Dividend (%)	10	--	--	20	20
Equity	600.30	600	600	300	300
Public Shareholding (Number)	--	--	--	--	--
Public Shareholding (%)	--	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--	--
PBIDTM(%)	22.79	25.77	28.62	31.44	25.62
PBDTM(%)	21.96	24.96	27.59	30.15	24.13
PATM(%)	9.43	11.85	13.82	18.18	10.99